======= TBCD ======= == Gene Information == * **Official Symbol**: TBCD * **Official Name**: tubulin folding cofactor D * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6904|6904]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BTW9|Q9BTW9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBCD&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBCD|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604649|Open OMIM]] == Function Summary == * **Entrez Summary**: Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |TFCD C| |post-chaperonin tubulin folding pathway| |tubulin complex assembly| |negative regulation of microtubule polymerization| |adherens junction assembly| |bicellular tight junction assembly| |negative regulation of microtubule polymerization or depolymerization| |tight junction assembly| |beta-tubulin binding| |tight junction organization| |apical junction assembly| |regulation of microtubule polymerization| |lateral plasma membrane| |negative regulation of cell-substrate adhesion| |adherens junction| |negative regulation of protein polymerization| |regulation of microtubule polymerization or depolymerization| |adherens junction organization| |chaperone binding| |cell-cell junction assembly| |bicellular tight junction| |negative regulation of protein complex assembly| |negative regulation of supramolecular fiber organization| |cell-cell junction organization| |negative regulation of cytoskeleton organization| |cell junction assembly| |regulation of microtubule cytoskeleton organization| |regulation of cell-substrate adhesion| |cell junction organization| |regulation of microtubule-based process| |regulation of protein polymerization| |protein folding| |negative regulation of cell adhesion| |GTPase activator activity| |microtubule| |regulation of supramolecular fiber organization| |negative regulation of organelle organization| |positive regulation of GTPase activity| |cell morphogenesis involved in neuron differentiation| |regulation of protein complex assembly| |microtubule cytoskeleton organization| |regulation of GTPase activity| |centrosome| |regulation of cytoskeleton organization| |cell morphogenesis involved in differentiation| |microtubule-based process| |regulation of cell adhesion| |mitotic cell cycle| |negative regulation of cellular component organization| |cell morphogenesis| |positive regulation of hydrolase activity| |neuron development| |cellular component morphogenesis| |cellular protein-containing complex assembly| |regulation of cellular component biogenesis| |neuron differentiation| |cytoskeleton organization| |regulation of hydrolase activity| |regulation of organelle organization| |cell cycle| |positive regulation of catalytic activity| |generation of neurons| |protein-containing complex assembly| |neurogenesis| |cell development| |positive regulation of molecular function| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp52|Ribavirin 10μM R01 exp52]]|-3.03| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.64| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|-2.55| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-2.43| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|-2.32| |[[:results:exp453|B02 10μM R08 exp453]]|-2.26| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-2.2| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.17| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-2.15| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-2.13| |[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|-2.08| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.04| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-2.01| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|-2| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-1.99| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.92| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-1.86| |[[:results:exp220|BAY-598 4μM R05 exp220]]|-1.85| |[[:results:exp360|Genistein 15μM R07 exp360]]|-1.85| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|-1.82| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.82| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|-1.82| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|-1.81| |[[:results:exp245|UM0011500 5μM R05 exp245]]|-1.81| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|-1.78| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|-1.77| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.74| |[[:results:exp211|AICAR 240μM R05 exp211]]|-1.73| |[[:results:exp423|Zebularine 20μM R07 exp423]]|-1.73| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|-1.7| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.572| |[[:human genes:a:arl2|ARL2]]|0.513| |[[:human genes:n:nsmce1|NSMCE1]]|0.484| |[[:human genes:n:nars|NARS]]|0.477| |[[:human genes:m:mars|MARS]]|0.473| |[[:human genes:e:eprs|EPRS]]|0.464| |[[:human genes:t:tbca|TBCA]]|0.461| |[[:human genes:h:hspd1|HSPD1]]|0.459| |[[:human genes:s:seh1l|SEH1L]]|0.439| |[[:human genes:s:sssca1|SSSCA1]]|0.438| |[[:human genes:t:tti2|TTI2]]|0.438| |[[:human genes:r:rnmt|RNMT]]|0.437| |[[:human genes:g:gmppb|GMPPB]]|0.437| |[[:human genes:y:yars|YARS]]|0.435| |[[:human genes:p:pmpcb|PMPCB]]|0.434| |[[:human genes:g:gtf3c3|GTF3C3]]|0.429| |[[:human genes:e:eif4e|EIF4E]]|0.428| |[[:human genes:c:csnk2b|CSNK2B]]|0.426| |[[:human genes:g:gtf3a|GTF3A]]|0.425| |[[:human genes:t:telo2|TELO2]]|0.417| |[[:human genes:p:polr3a|POLR3A]]|0.417| |[[:human genes:s:spcs2|SPCS2]]|0.415| |[[:human genes:p:pam16|PAM16]]|0.409| |[[:human genes:r:rptor|RPTOR]]|0.404| |[[:human genes:u:uxt|UXT]]|0.403| |[[:human genes:h:haus8|HAUS8]]|0.402| |[[:human genes:a:anapc13|ANAPC13]]|0.401| |[[:human genes:a:adsl|ADSL]]|0.401| |[[:human genes:r:rpe|RPE]]|0.4| Global Fraction of Cell Lines Where Essential: 449/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|20/28| |blood|18/28| |bone|19/26| |breast|18/33| |central nervous system|39/56| |cervix|3/4| |colorectal|10/17| |esophagus|8/13| |fibroblast|1/1| |gastric|10/16| |kidney|7/21| |liver|11/20| |lung|42/75| |lymphocyte|12/16| |ovary|13/26| |pancreas|10/24| |peripheral nervous system|11/16| |plasma cell|8/15| |prostate|1/1| |skin|9/24| |soft tissue|8/9| |thyroid|1/2| |upper aerodigestive|15/22| |urinary tract|18/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 932 * **Expression level (log2 read counts)**: 7.11 {{:chemogenomics:nalm6 dist.png?nolink |}}